Polycystic ovary syndrome (PCOS) isn’t that bad – if you’re a woman who’s a fan of fertility problems, irregular or absent periods, acne, and sporting excess facial hair.
This morning, Alydia Health announced that it has secured $10 million in funding to test a medical device to prevent mothers from bleeding to death after childbirth.
First, some good news: ovarian cancer is actually not all that common, with just 22,240 women diagnosed each year, according to the American Cancer Society.
There's a lot of misconceptions about what it means to live with polycystic ovary syndrome. And because people can't see what's causing me pain, my symptoms and my suffering are often overlooked.
Earlier this summer, James Van Der Beek and his wife, Kimberly, welcomed their fifth child into the world. The couple has taken to social media several times since to share their excitement.
Affecting as many as 5 million women in the U.S., polycystic ovary syndrome is one of the most common causes of female infertility, but most women don’t know how treatable PCOS actually is.
This fall, the Department of Obstetrics and Gynecology at Columbia University Irving Medical Center proudly welcomes five new full-time faculty members in four different divisions.
Babies are “due” after 40 weeks of gestation, but evidence suggests that infant mortality and complications are lowest for those delivered at 39 weeks, when a fetus is considered full term
